Sage Therapeutics | search
Click here to view Sage Therapeutics news from 60+ newspapers.
Bookmark or Share- Sage to abandon development of neurological disorder drug after ...Sage Therapeutics said on Wednesday it would stop the development of its experimental drug following the latest failure in a study testing it in patients with Huntington's disease, a rare...
- Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Acquired by State Street ...State Street Corp lifted its stake in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC ...
- Sage Therapeutics, Inc. (SAGE) Stock Price, News, Quote & History ...Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Sage Therapeutics (SAGE) Surges 12.2%: Is This an Indication ... - NasdaqSage Therapeutics, Inc. (SAGE) shares rallied 12.2% in the last trading session to close at $5.61. This move can be attributable to notable volume with a higher number of shares being traded than ...
- About Us - Sage TherapeuticsSage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.
More
